NASDAQ
COSM
Last Price
US $0.31
Valuation
Financial
Performance
Financial risk - Cash flow debt coverage.
Cosmos Health Inc. cash flow to debt ratio of -42.30% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.
Financial risk - Healthy cash flow growth.
Cosmos Health Inc.'s free cash flow has decreased 4.53% from $-8.14M last year to $-8.50M, signaling decreasing performance
Financial risk - Healthy debt to equity ratio.
Cosmos Health Inc.'s debt to equity ratio is 0.88, which means that the company's assets are unhealthy financed, signaling financial risk. READ MORE: A ratio over 0.60 means the company finances its assets with debt, signaling financial risk. If ratio is negative, the company spent its own equity and risks bankruptcy
Financial risk - Healthy debt to equity ratio development.
Cosmos Health Inc.'s debt has increased relative to shareholder equity from 0.48 last year to 0.88 today, signaling weakened financials
Financial risk - Net debt/EBITDA.
Cosmos Health Inc. has negative EBITDA, making leverage ratio unreliable
Financial risk - ICR.
Cosmos Health Inc.'s interest coverage ratio is -5.87, which means that the company struggles to meet interest obligations, signaling financial risk.
Financial risk - Profit margin growth.
Cosmos Health Inc.'s profit margin has decreased (2.28%) in the last year from -29.73% to -30.41%, signaling decreasing performance
Financial stability - Short term assets vs short term liabilities.
Cosmos Health Inc.'s short-term assets of $38.39M exceed its short-term liabilities of $38.27M
Decreasing performance - ROA.
Cosmos Health Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization
Decreasing performance - Absolute return on equity.
Cosmos Health Inc.'s return on equity of -96.48%, is lower than 15.00%, indicating bad performance
Decreasing performance - Earnings quality.
Cosmos Health Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation
Decreasing performance - Earnings stability.
Cosmos Health Inc. had positive net income in only 0.00 out of 5 years, indicating unstable earnings
Decreasing performance - Free cash flow.
Cosmos Health Inc. has negative free cash flow, indicating the company is burning cash rather than generating it
Decreasing performance - FCF yield.
Cosmos Health Inc. has negative free cash flow, indicating cash burn
Decreasing performance - Healthy earnings growth.
Cosmos Health Inc.'s yearly earnings has decreased 18.30% since last year from $-16.18M to $-19.14M, signaling decreasing performance
Increasing performance - Healthy revenue growth.
Cosmos Health Inc.'s yearly revenue has increased 19.93% since last year from $54.43M to $65.27M, signaling increasing performance
Decreasing performance - ROIC.
ROIC -45.73% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.
Increasing performance - 3-year revenue CAGR.
Cosmos Health Inc.'s 3-year revenue CAGR of 9.04% is positive, indicating growing revenue over the past 3 years
Increasing performance - Revenue consistency.
Cosmos Health Inc. had revenue growth in 4.00 out of 5 years, indicating consistent revenue performance
Decreasing performance - ROE consistency.
Cosmos Health Inc. had positive ROE in only 0.00 out of 5 years, indicating inconsistent returns on equity
Overvalued - DCF valuation.
Cosmos Health Inc. has insufficient data to evaluate this check.
Overvalued - Earnings yield.
Cosmos Health Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Overvalued - EBITDA valuation.
Cosmos Health Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model
Overvalued - EV/EBITDA.
Cosmos Health Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable
Overvalued - PEG ratio value.
Cosmos Health Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Undervalued - P/B ratio.
Cosmos Health Inc. has a price-to-book ratio of 0.73x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Undervalued - P/S ratio.
Cosmos Health Inc. has a price-to-sales ratio of 0.21x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue
Profit margin
Current Ratio
Capital Returns
-96.48%
Return on equity
ROIC: -45.73%
Valuation History
-0.44X
Price to Earnings
EV/EBITDA: -2.1X
Cash flow
Profit margin
-
(FY vs FY)
Cash flow Y/Y
6.44%
(FY vs FY)
Fair Value
Market $0.31
—
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.